Trial intelligence / Profile preview

Dexmedetomidine effect on Sevoflurane MAC in children

NCT03384563Phase 4Recruiting

Sponsor
Baylor College of Medicine
Start
Feb 2018
Primary completion
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of dexmedetomidine, sponsored by Baylor College of Medicine. Started Feb 2018; status: recruiting.

02

Drugs

dexmedetomidine

Beyond the preview

Go deeper on NCT03384563.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03384563.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call